Katsuhito Hashidzume
President at HUMAN METABOLOME TECHNOLOGIES, INC.
Net worth: 30 485 $ as of 2024-03-30
Profile
Katsuhito Hashidzume currently works at Human Metabolome Technologies, Inc., as President & Representative Director from 2019, HMT Biomedical KK, as President & Representative Director from 2018, and Mediome KK, as Non-Executive Director from 2018.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-06-29 | 7,044 ( 0.12% ) | 30 485 $ | 2024-03-30 |
Katsuhito Hashidzume active positions
| Companies | Position | Start |
|---|---|---|
| HUMAN METABOLOME TECHNOLOGIES, INC. | President | 2019-09-20 |
HMT Biomedical KK
 HMT Biomedical KK Pharmaceuticals: MajorHealth Technology Part of Human Metabolome Technologies, Inc., HMT Biomedical KK is a Japanese company that operates in the metabolomics business. The company's description is in Japanese, but it can be translated to mean that it is a domestic information site for HMT, which is a company that develops metabolomics technology. | President | 2018-11-30 |
| Mediome KK | Director/Board Member | 2018-11-30 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| HUMAN METABOLOME TECHNOLOGIES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
HMT Biomedical KK
HMT Biomedical KK Pharmaceuticals: MajorHealth Technology Part of Human Metabolome Technologies, Inc., HMT Biomedical KK is a Japanese company that operates in the metabolomics business. The company's description is in Japanese, but it can be translated to mean that it is a domestic information site for HMT, which is a company that develops metabolomics technology. | Health Technology |
| Mediome KK |
- Stock Market
- Insiders
- Katsuhito Hashidzume
